Press Releases Pharmaron Beijing Co., Ltd.

Equities

300759

CNE100003JW4

End-of-day quote Shenzhen S.E. Other stock markets 06:00:00 2024-04-25 pm EDT			5-day change	1st Jan Change
19.16 ^CNY	+5.04%		+5.39%	-33.89%

10:34am	Nomura Adjusts Pharmaron’s Price Target to 31.41 Yuan From 36.68 Yuan, Keeps at Buy	MT
Apr. 26	Pharmaron Beijing Posts 34% Profit Drop in Q1 as Revenue Slips 2%	MT

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

CORRECTION, Skye Bioscience to Host Virtual Investor Day on October 25, 2023, 'CB1 Axis: Unlocking the Pharmaceutical Potential of the Endocannabinoid System'	23-10-23	AQ
Pharmaron's Liverpool UK Gene Therapy CDMO Commences Major Site Expansion Following UK Government Grant to Support GBP151m Investment	23-03-30	AQ
Pharmaron’s Liverpool UK Gene Therapy CDMO Commences Major Site Expansion Following UK Government Grant to Support £151m Investment	23-03-29	BU
Pharmaron Acquires Commercial API Manufacturing Facility in the United States	22-05-24	BU
Pharmaron Beijing : An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section	22-02-24	PU
Pharmaron Appoints Dr. Antony Davies as Senior Vice President, UK CMC	22-01-16	BU
Pharmaron Acquires Commercial API Manufacturing Facility in the United Kingdom from Recipharm	22-01-09	BU
Pharmaron recognized with 2 Awards at China Securities Golden Bauhinia Awards Ceremony	21-12-17	AQ
Pharmaron Announces Promotion of Ms. Katherine Lee to Chief Business Officer	21-11-05	BU
Pharmaron Beijing : CLOSURE OF REGISTER OF MEMBERS FOR THE FIRST H SHARES CLASS MEETING OF 2021	21-04-30	PU
Pharmaron Beijing : Reply Slip for the First H Shares Class Meeting of 2021	21-04-28	PU
Pharmaron Beijing : Reply Slip for the Annual General Meeting of 2020 (Applicable to H Shareholders)	21-04-28	PU
Pharmaron Beijing : Form of Proxy for the First H Shares Class Meeting of 2021	21-04-28	PU
Pharmaron Beijing : Form of Proxy for the Annual General Meeting of 2020 (Applicable to H Shareholders)	21-04-28	PU
Pharmaron Beijing : NOTICE OF THE FIRST H SHARES CLASS MEETING OF 2021	21-04-28	PU
Pharmaron Beijing : NOTICE OF THE ANNUAL GENERAL MEETING OF 2020	21-04-28	PU
Pharmaron Beijing : REPORT OF BOARD & SUPERVISORY COMMITTEE; FINANCIAL STATEMENTS; PROFIT DISTRIBUTION PLAN; ANNUAL REPORT, REPORT SUMMARY & ANNUAL RESULTS ANNOUNCEMENT; REMUNERATION OF DIRECTORS & SUPERVISORS; ENGAGEMENT OF AUDITORS; GUARANTEES & FOREIGN EXCHANGE HEDGING QUOTA; REPURCHASE & CANCELLATION OF RESTRICTED A SHARES; REDUCTION OF REGISTERED CAPITAL, AMENDMENTS TO THE ARTICLES & REGISTRATION; GRANTING OF GENERAL MANDATE TO ISSUE SHARES; NOTICES OF ANNUAL GENERAL MEETING & 2021 FIRST H SHARES CLASS	21-04-28	PU
Pharmaron Beijing : PROPOSED REDUCTION OF REGISTERED CAPITAL AND PROPOSED AMENDMENTS TO THE ARTICLES OF ASSOCIATION	21-03-28	PU
Pharmaron Beijing : ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2020	21-03-28	PU
Pharmaron Beijing : Acquires State-of-the-Art Biomanufacturing Site in the United Kingdom from AbbVie	21-02-28	BU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Pharmaron Beijing Co., Ltd.

Equities

300759

CNE100003JW4

Press Releases

Filters